SCHEMBL24896576

SCHEMBL24896576

CN(C)c1nccc2cc(C(=O)O)n(C)c12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 2/20 0.43
ALDH1A1 P00352 7/20 0.40
KDM4E B2RXH2 5/20 0.40
HPGD P15428 4/20 0.40
HSD17B10 Q99714 3/20 0.40
GPR35 Q9HC97 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.38
SRD5A2 P31213 2/20 0.36
CYP1A2 P05177 1/20 0.35
POLB P06746 1/20 0.35
GLA P06280 1/20 0.34
ATM Q13315 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
SRD5A1 P18405 1/20 0.34
CSNK2A1 P68400 1/20 0.34
HIPK2 Q9H2X6 1/20 0.34
GAA P10253 2/20 0.33
GFER P55789 1/20 0.33
SYK P43405 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30220530 0.81 SMN1; SMN2 (0.41) ALDH1A1KDM4ESMN1; SMN2CYP1A2MAPT
SCHEMBL24896374 0.80 MCL1 (0.46) MCL1ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL20504453 0.79 MCL1 (0.45) MCL1ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL24896258 0.77 KDM4E (0.50) MCL1ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL24896316 0.77 MCL1 (0.43) MCL1ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL24896273 0.76 GRM4 (0.38)
SCHEMBL25003585 0.76
SCHEMBL24896365 0.75 HSD17B10 (0.42) MCL1ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL30220596 0.75 HSD17B10 (0.42) MCL1ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL24896308 0.74 MCL1 (0.41) MCL1ALDH1A1KDM4EHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4370207-A1 BICYCLIC COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS Nido Biosciences, Inc. (US) 2024-05-22 EP disclosed
US-20230039586-A1 BICYCLIC COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS NIDO BIOSCIENCES, INC. 2023-02-09 US disclosed
WO-2023287704-A1 BICYCLIC COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS NIDO BIOSCIENCES, INC. (US) 2023-01-19 WO disclosed
WO-2023287704-A1 BICYCLIC COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS NIDO BIOSCIENCES, INC. (US) 2023-01-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230039586-A1 BICYCLIC COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS AR, FSHR, NR5A1 MCL1 4696/4885ALDH1A1 2558/4885KDM4E 1723/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.